Thursday, April 17, 2014

Sources: DME, Provider Taxes, Blended FMAP Targets Eyed As Medicaid Cut Options -- But Extending Drug Rebates Off Table

Debt limit negotiators are no longer considering extending Medicaid rebates to dually eligible beneficiaries or those in the Medicare low-income subsidy program due to heavy drug industry opposition, several sources tell Inside Health Policy.

You've followed a link to an article or document on
There are three ways you can access this content.

Subscriber Login

If you are an subscriber, or you have an active trial subscription, please login here:

Take A Trial Subscription

If you haven't already had a trial subscription to, you can sign up for one right now. Just click on the link below to get started -- you'll get full access for one month, including access to our newsletters, Inside CMS and FDA Week, plus daily news updates by e-mail and much, much more.

Sign up for a trial subscription.

Buy This Article

You can also buy this and other individual articles by going to the NewsStand. Articles are $5 apiece. We'll even give you your first download free.

Here's a direct link to this article on the NewsStand.